Neutral
Last updated: 2026-08-27 15:08:24 ET
The startup is only a year old but it has already generated a massive amount of hype (and money) while also spurring privacy concerns.
From consumer brands to Asian tech, Ranmore Fund Management's Sean Peche shares some of his top unloved stock picks.
Doctors and patients are excited about the possible breakthrough, but some analysts believe there’s too much hype.
HYPE reached $72 after Trump said the CFTC was pursuing compliant US access for Hyperliquid, though no formal regulatory plan has been released.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE